233 related articles for article (PubMed ID: 33356695)
21. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Dowdell KC; Niemela JE; Price S; Davis J; Hornung RL; Oliveira JB; Puck JM; Jaffe ES; Pittaluga S; Cohen JI; Fleisher TA; Rao VK
Blood; 2010 Jun; 115(25):5164-9. PubMed ID: 20360470
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
[TBL] [Abstract][Full Text] [Related]
23. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
Ramenghi U; Bonissoni S; Migliaretti G; DeFranco S; Bottarel F; Gambaruto C; DiFranco D; Priori R; Conti F; Dianzani I; Valesini G; Merletti F; Dianzani U
Blood; 2000 May; 95(10):3176-82. PubMed ID: 10807785
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in FAS and CASP8 genes may contribute to the development of ALPS phenotype: a study in 25 patients with probable ALPS.
Tan Ç; Özgül RK; Çağdaş Ayvaz D; Tezcan İ; Sanal Ö
Turk J Pediatr; 2015; 57(2):141-5. PubMed ID: 26690594
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
[TBL] [Abstract][Full Text] [Related]
26. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
Gámez-Díaz L; Grimbacher B
Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Magerus-Chatinet A; Stolzenberg MC; Lanzarotti N; Neven B; Daussy C; Picard C; Neveux N; Desai M; Rao M; Ghosh K; Madkaikar M; Fischer A; Rieux-Laucat F
J Allergy Clin Immunol; 2013 Feb; 131(2):486-90. PubMed ID: 22857792
[TBL] [Abstract][Full Text] [Related]
28. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A; Niu J; Chang C
Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
[TBL] [Abstract][Full Text] [Related]
30. Scaling the tips of the ALPS.
Rieux-Laucat F; Kanellopoulos JM; Ojcius DM
Biomed J; 2021 Aug; 44(4):383-387. PubMed ID: 34438083
[TBL] [Abstract][Full Text] [Related]
31. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
[TBL] [Abstract][Full Text] [Related]
32. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
Jackson CE; Puck JM
Curr Opin Pediatr; 1999 Dec; 11(6):521-7. PubMed ID: 10590910
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
[TBL] [Abstract][Full Text] [Related]
35. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
Front Immunol; 2018; 9():718. PubMed ID: 29686686
[TBL] [Abstract][Full Text] [Related]
37. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
Poppema S; Maggio E; van den Berg A
Leuk Lymphoma; 2004 Mar; 45(3):423-31. PubMed ID: 15160902
[TBL] [Abstract][Full Text] [Related]
38. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Neven B; Magerus-Chatinet A; Florkin B; Gobert D; Lambotte O; De Somer L; Lanzarotti N; Stolzenberg MC; Bader-Meunier B; Aladjidi N; Chantrain C; Bertrand Y; Jeziorski E; Leverger G; Michel G; Suarez F; Oksenhendler E; Hermine O; Blanche S; Picard C; Fischer A; Rieux-Laucat F
Blood; 2011 Nov; 118(18):4798-807. PubMed ID: 21885602
[TBL] [Abstract][Full Text] [Related]
39. The genetic landscape of the FAS pathway deficiencies.
Magerus A; Bercher-Brayer C; Rieux-Laucat F
Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
[TBL] [Abstract][Full Text] [Related]
40. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.
Janda A; Schwarz K; van der Burg M; Vach W; Ijspeert H; Lorenz MR; Elgizouli M; Pieper K; Fisch P; Hagel J; Lorenzetti R; Seidl M; Roesler J; Hauck F; Traggiai E; Speckmann C; Rensing-Ehl A; Ehl S; Eibel H; Rizzi M
Blood; 2016 May; 127(18):2193-202. PubMed ID: 26907631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
